GSK Plc (GSK)
59.53
-1.32
(-2.17%)
USD |
NYSE |
Feb 20, 16:00
59.53
0.00 (0.00%)
After-Hours: 20:00
GSK Market Cap : 119.46B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 316.92B |
| Mereo BioPharma Group Plc | 67.45M |
| Novavax, Inc. | 1.498B |
| Biodexa Pharmaceuticals Plc | 0.9647M |
| AnaptysBio, Inc. | 1.502B |
Market Cap Related Metrics
| PE Ratio | 16.25 |
| PS Ratio | 2.837 |
| PEG Ratio | 0.1236 |
| Price to Book Value | 5.423 |
| Price to Free Cash Flow | 21.41 |
| Price | 59.53 |
| Earnings Yield | 6.15% |
| PEGY Ratio | 0.1209 |
| Operating PE Ratio | 12.57 |
| Normalized PE Ratio | 15.05 |